Silk Road Medical Inc - Company Profile
Powered by 
All the data and insights you need on Silk Road Medical Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Silk Road Medical Inc Strategy Report
- Understand Silk Road Medical Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Silk Road Medical Inc (Silk Road) develops and manufactures medical devices for the treatment of carotid artery diseases. The company’s product portfolio includes the ENROUTE trans carotid neuroprotection system, ENROUTE trans carotid stent system, ENHANCE trans carotid peripheral access kit and ENROUTE 0.014” guidewire. Silk Road focuses to develop therapies for carotid artery disease called trans carotid artery revascularization (TCAR). Its TCAR approach combines surgical principles of neuroprotection with invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The company offers products under the brand names Enroute and Enhance. Silk Road is headquartered in Sunnyvale, California, the US.
Headquarters
United States of America
Address
1213 Innsbruck Dr, Sunnyvale, California, 94089-1317
Website
silkroadmed.com
Telephone
1 650 5669060
No of Employees
414
Industry
Medical Equipment
Ticker Symbol & Exchange
SILK (NASD)
Revenue (2022)
$177.1M
27.8%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-1.3%
(2022 vs 2021)
Market Cap*
$691.4M
Net Profit Margin (2022)
XYZ
20.7%
(2022 vs 2021)
* As of and is in US$
Silk Road Medical Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| ENROUTE Transcarotid Neuroprotection System | Enroute |
| ENHANCE Transcarotid Peripheral Access Kit | Enhance |
| ENROUTE Transcarotid Stent System | TCAR |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | New Products/Services | In April, the company introduced its ENROUTE Transcarotid Neuroprotection System PLUS. |
| 2024 | Contracts/Agreements | In March, the company and Genesis MedTech Group entered into a distribution partnership to launch the TCAR core products, ENROUTE Transcarotid Neuroprotection System and ENROUTE Transcarotid Stent System, in China. |
| 2024 | New Products/Services | In March, the company introduced its Tapered ENROUTE Transcarotid Stent System to hospitals in the US. |
Competitor Comparison
| Key Parameters | Silk Road Medical Inc | Stryker Corp | Inspire Medical Systems Inc | SI-Bone Inc | Bolton Medical Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Sunnyvale | Kalamazoo | Golden Valley | Santa Clara | Sunrise |
| State/Province | California | Michigan | Minnesota | California | Florida |
| No. of Employees | 414 | 52,000 | 1,011 | 344 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jack W. Lasersohn | Chairman | Executive Board | 2021 | 69 |
| Chas McKhann | Chief Executive Officer | Senior Management | 2023 | - |
| Lucas W. Buchanan | Chief Operating Officer; Chief Financial Officer | Senior Management | 2020 | 45 |
| Kevin M. Klemz | Executive Vice President; Secretary; Chief Legal Officer | Senior Management | 2022 | 61 |
| Alison Highlander | Vice President - Human Resources | Senior Management | 2017 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer